EC: 3.1.1.56
methylumbelliferyl-acetate deacetylase (4-methylumbelliferyl-acetate acylhydrolase)
Pathways
| pathway id | name |
|---|---|
| BioCyc:HUMAN_PWY-1801 | formaldehyde oxidation |
| BioCyc:META_PWY-6857 | retinol biosynthesis |
| BioCyc:HUMAN_PWY-6857 | retinol biosynthesis |
| Reactome:R-HSA-9749641 | Aspirin ADME |
| Reactome:R-HSA-9748784 | Drug ADME |
| Reactome:R-HSA-211859 | Biological oxidations |
| Reactome:R-HSA-5578768 | Physiological factors |
| Reactome:R-HSA-392499 | Metabolism of proteins |
| Reactome:R-HSA-156580 | Phase II - Conjugation of compounds |
| Reactome:R-HSA-2980736 | Peptide hormone metabolism |
| Reactome:R-HSA-156590 | Glutathione conjugation |
| Reactome:R-HSA-5576891 | Cardiac conduction |
| Reactome:R-HSA-1430728 | Metabolism |
| Reactome:R-HSA-397014 | Muscle contraction |
| Reactome:R-HSA-2022377 | Metabolism of Angiotensinogen to Angiotensins |
| PathBank:SMP0000469 | Capecitabine Action Pathway |
| PathBank:SMP0000600 | Irinotecan Metabolism Pathway |
| PathBank:SMP0000652 | Mycophenolic Acid Metabolism Pathway |
| PathBank:SMP0000433 | Irinotecan Action Pathway |
| PathBank:SMP0000607 | Capecitabine Metabolism Pathway |
| PathBank:SMP0000623 | Heroin Metabolism Pathway |